chronic myelomonocytic leukemia

Showing 1 - 25 of 159

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
    • (no location specified)
    Nov 1, 2023

    Chronic Myelomonocytic Leukemia Trial in Houston (Azacitidine, Tamibarotene, Venetoclax)

    Not yet recruiting
    • Chronic Myelomonocytic Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 10, 2023

    Chronic Myelomonocytic Leukemia Trial in Indianapolis (CD4CAR)

    Not yet recruiting
    • Chronic Myelomonocytic Leukemia
    • CD4CAR
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Oct 2, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +10 more
    • Jacksonville, Florida
    • +5 more
    Aug 14, 2023

    MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)

    Recruiting
    • Myelodysplastic Syndromes
    • Chronic Myelomonocytic Leukemia
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital, Chinese Acade
    Jul 30, 2023

    Bone Marrow Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Adult Trial in Indianapolis

    Not yet recruiting
    • Bone Marrow Transplant Complications
    • +4 more
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    May 30, 2023

    MDS, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Aachen, Düsseldorf, Jena (Venetoclax, Amsacrine,

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Aachen, NRW, Germany
    • +2 more
    Mar 29, 2023

    Acute Myelogenous Leukemia, Chronic Myelomonocytic Leukemia Trial in Tianjin (LILRB4 STAR-T cells injection)

    Not yet recruiting
    • Acute Myelogenous Leukemia
    • Chronic Myelomonocytic Leukemia
    • LILRB4 STAR-T cells injection
    • Tianjin, Tianjin, China
    • +1 more
    Feb 12, 2023

    Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United

    Active, not recruiting
    • Chronic Myelomonocytic Leukemia
    • +6 more
    • Birmingham, Alabama
    • +297 more
    Jan 28, 2023

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +9 more
    • Los Angeles, California
    • +5 more
    Jan 27, 2023

    Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Worldwide (JNJ-74856665, AZA, VEN)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Birmingham, Alabama
    • +22 more
    Jan 27, 2023

    Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

    Active, not recruiting
    • Myelofibrosis
    • Chronic Myelomonocytic Leukemia
    • Duarte, California
    • +9 more
    Jan 24, 2023

    Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    Recruiting
    • Acute Bilineal Leukemia
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 24, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +36 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jan 23, 2023

    Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

    Active, not recruiting
    • Leukemia
    • +7 more
    • Boston, Massachusetts
    • +10 more
    Jan 19, 2023

    Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

    Recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Biospecimen Collection
    • +3 more
    • Baltimore, Maryland
    • +2 more
    Jan 19, 2023

    Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

    Recruiting
    • Myelofibrosis
    • +2 more
    • Charlottesville, Virginia
      Danyelle Coley
    Jan 18, 2023

    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Scottsdale, Cleveland,

    Completed
    • Chronic Myelomonocytic Leukemia
    • +3 more
    • Scottsdale, Arizona
    • +3 more
    Jan 12, 2023

    Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

    Suspended
    • Juvenile Myelomonocytic Leukemia
    • +27 more
    • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023

    MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Sydney (Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET,

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET
    • Defactinib
    • Sydney, New South Wales, Australia
    • +3 more
    Jan 12, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +15 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Chicago, Illinois
    • +2 more
    Jan 12, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +6 more
    • Duarte, California
      City of Hope Medical Center
    Dec 8, 2022

    Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Chronic Myelomonocytic Leukemia Trial in Houston

    Recruiting
    • Chronic Myelomonocytic Leukemia
    • +5 more
    • Canakinumab
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 7, 2022

    Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial (LP-108, Azacitidine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • (no location specified)
    Nov 29, 2022